Literature DB >> 26757917

Is Bariatric Surgery Effective in Reducing Comorbidities and Drug Costs? Reply to Letter to the Editor.

Edyane Cardoso Lopes1,2, Isabela Heineck3, Nelson Guardiola Meinhardt4, Airton Tetelbom Stein5,6,7.   

Abstract

Mesh：

Year:  2016        PMID： 26757917     DOI： 10.1007/s11695-016-2046-y

Source DB:  PubMed          Journal:  Obes Surg        ISSN： 0960-8923            Impact factor:   4.129


× No keyword cloud information.
  6 in total

1.  Impact of bariatric surgery on health care utilization and costs among patients with diabetes.

Authors:  Sara N Bleich; Hsien-Yen Chang; Bryan Lau; Kimberly Steele; Jeanne M Clark; Thomas Richards; Jonathan P Weiner; Albert W Wu; Jodi B Segal
Journal:  Med Care       Date:  2012-01       Impact factor: 2.983

Review 2.  "Obesity paradox" in coronary artery disease.

Authors:  Ibrahim Akin; Christoph A Nienaber
Journal:  World J Cardiol       Date:  2015-10-26

Review 3.  Is Bariatric Surgery Effective in Reducing Comorbidities and Drug Costs? A Systematic Review and Meta-Analysis.

Authors:  E C Lopes; I Heineck; G Athaydes; N G Meinhardt; K E P Souto; A T Stein
Journal:  Obes Surg       Date:  2015-09       Impact factor: 4.129

4.  Short-term medication cost savings for treating hypertension and diabetes after gastric bypass.

Authors:  Saber Ghiassi; John Morton; Nina Bellatorre; Dan Eisenberg
Journal:  Surg Obes Relat Dis       Date:  2011-05-27       Impact factor: 4.734

5.  Actual medical and pharmacy costs for bariatric surgery: 6-year follow-up.

Authors:  Valerie H Myers; Megan A McVay; Claire E Adams; Brooke L Barbera; Meghan M Brashear; William D Johnson; Patricia Smith Boyd; Phillip J Brantley
Journal:  South Med J       Date:  2012-10       Impact factor: 0.954

6.  Medication cost is significantly reduced after Roux-en-Y gastric bypass in obese patients.

Authors:  Ina Gesquiere; Judith Aron-Wisnewsky; Veerle Foulon; Steeve Haggege; Bart Van der Schueren; Patrick Augustijns; Jean-Luc Bouillot; Karine Clement; Arnaud Basdevant; Jean-Michel Oppert; Marion Buyse
Journal:  Obes Surg       Date:  2014-11       Impact factor: 4.129
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.